ESC Premium Access

Insights from the first trials in epigenetics in human: what is the way forward?

Topic: Drug therapy
Organised by Physicians' Academy for Cardiovascular Education, supported with an educational grant by Resverlogix

Congress Presentation

About the speaker

Professor Stephen Nicholls

Monash Heart, Melbourne (Australia)
37 presentations
4 followers

4 more presentations in this session

Introduction - Managing diabetes & CVD: is epigenetics a new way forward?

Speaker: Professor L. Badimon (Barcelona, ES)

Thumbnail

Managing high risk diabetes patient with cardiovascular disease: what works, and what else can we do?

Speaker: Professor R. Kausik

Thumbnail

Promise of epigenetic modulation as a target in atherosclerotic patients.

Speaker: Professor E. Stroes (Amsterdam, NL)

Thumbnail

Discussion - Managing diabetes & CVD: is epigenetics a new way forward?

Speaker: Professor R. Kausik

Thumbnail

Access the full session

Managing diabetes & cardiovascular disease (CVD): is epigenetics a new way forward? (EBAC Accredited)

Speakers: Professor S. Nicholls, Professor L. Badimon, Professor R. Kausik, Professor E. Stroes, Professor R. Kausik
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk